BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24562768)

  • 1. Regulatory RNAs and paracrine networks in the heart.
    Viereck J; Bang C; Foinquinos A; Thum T
    Cardiovasc Res; 2014 May; 102(2):290-301. PubMed ID: 24562768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.
    Bang C; Batkai S; Dangwal S; Gupta SK; Foinquinos A; Holzmann A; Just A; Remke J; Zimmer K; Zeug A; Ponimaskin E; Schmiedl A; Yin X; Mayr M; Halder R; Fischer A; Engelhardt S; Wei Y; Schober A; Fiedler J; Thum T
    J Clin Invest; 2014 May; 124(5):2136-46. PubMed ID: 24743145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular communication lessons in heart failure.
    Bang C; Antoniades C; Antonopoulos AS; Eriksson U; Franssen C; Hamdani N; Lehmann L; Moessinger C; Mongillo M; Muhl L; Speer T; Thum T
    Eur J Heart Fail; 2015 Nov; 17(11):1091-103. PubMed ID: 26398116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac nonmyocytes in the hub of cardiac hypertrophy.
    Kamo T; Akazawa H; Komuro I
    Circ Res; 2015 Jun; 117(1):89-98. PubMed ID: 26089366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endothelial cell in cardiac hypertrophy: Focusing on angiogenesis and intercellular crosstalk.
    Yang X; Cheng K; Wang LY; Jiang JG
    Biomed Pharmacother; 2023 Jul; 163():114799. PubMed ID: 37121147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as New Intercellular Mediators in Development and Therapeutics of Cardiomyocyte Hypertrophy.
    Huang Q; Cai B
    Adv Exp Med Biol; 2017; 998():91-100. PubMed ID: 28936734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cardiomyocyte microRNAs in heart failure.
    Tijsen AJ; Pinto YM; Creemers EE
    Cardiovasc Res; 2012 Mar; 93(4):573-82. PubMed ID: 22180601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators.
    Cartledge JE; Kane C; Dias P; Tesfom M; Clarke L; Mckee B; Al Ayoubi S; Chester A; Yacoub MH; Camelliti P; Terracciano CM
    Cardiovasc Res; 2015 Mar; 105(3):260-70. PubMed ID: 25560320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
    Martin ML; Blaxall BC
    J Cardiovasc Transl Res; 2012 Dec; 5(6):768-82. PubMed ID: 23015462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-mediated pathways in cardiac hypertrophy.
    Fujiu K; Nagai R
    J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy.
    Indolfi C; Curcio A
    J Clin Invest; 2014 May; 124(5):1896-8. PubMed ID: 24743143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation.
    Sassi Y; Ahles A; Truong DJ; Baqi Y; Lee SY; Husse B; Hulot JS; Foinquinos A; Thum T; Müller CE; Dendorfer A; Laggerbauer B; Engelhardt S
    J Clin Invest; 2014 Dec; 124(12):5385-97. PubMed ID: 25401477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communication signals between cardiac fibroblasts and cardiac myocytes.
    Ottaviano FG; Yee KO
    J Cardiovasc Pharmacol; 2011 May; 57(5):513-21. PubMed ID: 21297490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
    Creemers EE; Pinto YM
    Cardiovasc Res; 2011 Feb; 89(2):265-72. PubMed ID: 20880837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
    Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
    J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism.
    Accornero F; van Berlo JH; Benard MJ; Lorenz JN; Carmeliet P; Molkentin JD
    Circ Res; 2011 Jul; 109(3):272-80. PubMed ID: 21636802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
    Kaye DM; Kelly RA; Smith TW
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S136-41. PubMed ID: 21143287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of miRNA in cardiac hypertrophy.
    Wang J; Yang X
    Cell Mol Life Sci; 2012 Nov; 69(21):3561-70. PubMed ID: 22926414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in heart failure: from biomarker to target for therapy.
    Vegter EL; van der Meer P; de Windt LJ; Pinto YM; Voors AA
    Eur J Heart Fail; 2016 May; 18(5):457-68. PubMed ID: 26869172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.